I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Cejalvo, J.M.
~ 100
results:
Search for persons
X
Format
Online
Mediatypes
Articles (Online)
OpenAccess-fulltext
Sorted by: Relevance
Sorted by: Year
?
1
265TiP SOLTI-2201 ACROSS-TROP2 trial: A phase II study to i..:
Ciruelos, E.M.
;
Pascual, T.
;
Vazquez, R. Villanueva
...
ESMO Open. 9 (2024) - p. 103286 , 2024
Link:
https://doi.org/10.1016/..
?
2
74P Assessing the implementation of the HER2DX genomic test..:
Cejalvo, J.M.
;
Soberino, J.
;
Ciruelos, E.M.
...
ESMO Open. 9 (2024) - p. 103080 , 2024
Link:
https://doi.org/10.1016/..
?
3
197P ATREZZO trial (SOLTI-1907): A phase II trial targeting..:
Ciruelos, E.M.
;
Ortega, P. Tolosa
;
Bofill, F.J. Salvador
...
ESMO Open. 8 (2023) 1 - p. 101386 , 2023
Link:
https://doi.org/10.1016/..
?
4
124O Patritumab deruxtecan (HER3-DXd) in hormonal receptor-..:
Oliveira, M.
;
Pascual, T.
;
Ortega, P. Tolosa
...
ESMO Open. 8 (2023) 1 - p. 101463 , 2023
Link:
https://doi.org/10.1016/..
?
5
In the literature: May 2023:
Gambardella, V.
;
Cejalvo, J.-M.
;
Cervantes, A.
ESMO Open. 8 (2023) 3 - p. 101562 , 2023
Link:
https://doi.org/10.1016/..
?
6
In the Literature: January 2023:
Martín-Arana, J.
;
Gambardella, V.
;
Tarazona, N.
..
ESMO Open. 8 (2023) 1 - p. 100763 , 2023
Link:
https://doi.org/10.1016/..
?
7
3MO HER2 expression and early response to patritumab deruxt..:
Brasó-Maristany, F.
;
Oliveira, M.
;
Ortega, P. Tolosa
...
ESMO Open. 8 (2023) 1 - p. 101227 , 2023
Link:
https://doi.org/10.1016/..
?
8
155TiP A randomised phase II trial of neoadjuvant multi-age..:
Oliveira, M.
;
Pascual, T.
;
Villacampa, G.
...
ESMO Open. 8 (2023) 1 - p. 101494 , 2023
Link:
https://doi.org/10.1016/..
?
9
Patritumab deruxtecan in untreated hormone receptor-positiv..:
Oliveira, M.
;
Falato, C.
;
Cejalvo, J.M.
...
Annals of Oncology. 34 (2023) 8 - p. 670-680 , 2023
Link:
https://doi.org/10.1016/..
?
10
74P Transcriptomic profile identifies biological difference..:
Garrido-Cano, I.
;
Céspedes, M. Tapia
;
Carbonell-Asins, J.A.
...
ESMO Open. 8 (2023) 1 - p. 101297 , 2023
Link:
https://doi.org/10.1016/..
?
11
In the literature: November 2022:
Gambardella, V.
;
Cejalvo, J.-M.
;
Cervantes, A.
ESMO Open. 7 (2022) 6 - p. 100643 , 2022
Link:
https://doi.org/10.1016/..
?
12
Phosphoproteomic analysis of neoadjuvant breast cancer sugg..:
Mouron, S.
;
Bueno, M. J.
;
Lluch, A.
...
Nature Communications. 13 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
13
In the literature: February 2022:
Gambardella, V.
;
Cejalvo, J.M.
;
González-Barrallo, I.
..
ESMO Open. 7 (2022) 2 - p. 100411 , 2022
Link:
https://doi.org/10.1016/..
?
14
In the literature: April 2021:
Martín-Martorell, P.
;
Gonzalez-Barrallo, I.
;
Gambardella, V.
..
ESMO Open. 6 (2021) 3 - p. 100116 , 2021
Link:
https://doi.org/10.1016/..
?
15
In the literature: August 2021:
Gambardella, V.
;
Alfaro-Cervelló, C.
;
Cejalvo, J.M.
..
ESMO Open. 6 (2021) 5 - p. 100247 , 2021
Link:
https://doi.org/10.1016/..
1-15